Immunohistochemical application of a highly sensitive and specific murine monoclonal antibody recognising the extracellular domain of the human hepatocyte growth factor receptor (MET). (Q53878549)

From Wikidata

Jump to navigation Jump to search

scientific article published on 6 October 2014

Language	Label	Description	Also known as
English	Immunohistochemical application of a highly sensitive and specific murine monoclonal antibody recognising the extracellular domain of the human hepatocyte growth factor receptor (MET).	scientific article published on 6 October 2014

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/25039923

Immunohistochemical application of a highly sensitive and specific murine monoclonal antibody recognising the extracellular domain of the human hepatocyte growth factor receptor (MET). (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/25039923

immunohistochemistry

1 reference

based on heuristic

inferred from title

Timothy R Holzer

object named as

Timothy R Holzer

11

0 references

author name string

Aaron M Gruver

1

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/25039923

Ling Liu

2

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/25039923

Peter Vaillancourt

3

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/25039923

Sau-Chi B Yan

4

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/25039923

Joel D Cook

5

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/25039923

Jessica A Roseberry Baker

6

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/25039923

Erin M Felke

7

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/25039923

Megan E Lacy

8

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/25039923

Christophe C Marchal

9

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/25039923

Hadrian Szpurka

10

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/25039923

Emily K Rhoads

12

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/25039923

Wei Zeng

13

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/25039923

Mark A Wortinger

14

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/25039923

Jirong Lu

15

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/25039923

Chi-kin Chow

16

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/25039923

Irene J Denning

17

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/25039923

Gregory Beuerlein

18

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/25039923

Julian Davies

19

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/25039923

Jeff C Hanson

20

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/25039923

Kelly M Credille

21

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/25039923

Sameera R Wijayawardana

22

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/25039923

Andrew E Schade

23

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/25039923

publication date

6 October 2014

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/25039923

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/25039923

65

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/25039923

6

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/25039923

879-896

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/25039923

Met, metastasis, motility and more

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12510

21 January 2018

An overview of the c-MET signaling pathway

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12510

21 January 2018

Population pharmacokinetics of rilotumumab, a fully human monoclonal antibody against hepatocyte growth factor, in cancer patients

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12510

21 January 2018

LY2801653 is an orally bioavailable multi-kinase inhibitor with potent activity against MET, MST1R, and other oncoproteins, and displays anti-tumor activities in mouse xenograft models

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12510

21 January 2018

Randomized phase II trial of Onartuzumab in combination with erlotinib in patients with advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12510

21 January 2018

The emerging role of MET/HGF inhibitors in oncology

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12510

21 January 2018

Antibody validation

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12510

21 January 2018

MET overexpression assessed by new interpretation method predicts gene amplification and poor survival in advanced gastric carcinomas

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12510

21 January 2018

Correlation between MET gene copy number by silver in situ hybridization and protein expression by immunohistochemistry in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12510

21 January 2018

Antibody validation by quantitative analysis of protein expression using expression of Met in breast cancer as a model

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12510

21 January 2018

A novel multipurpose monoclonal antibody for evaluating human c-Met expression in preclinical and clinical settings

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12510

21 January 2018

Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens.

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12510

21 January 2018

Tumor cell expression of vascular endothelial growth factor receptor 2 is an adverse prognostic factor in patients with squamous cell carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12510

21 January 2018

HER4 expression status correlates with improved outcome in both neoadjuvant and adjuvant Trastuzumab treated invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12510

21 January 2018

Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12510

21 January 2018

Mechanisms of acquired resistance to EGFR-tyrosine kinase inhibitor in Korean patients with lung cancer.

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12510

21 January 2018

MET phosphorylation predicts poor outcome in small cell lung carcinoma and its inhibition blocks HGF-induced effects in MET mutant cell lines

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12510

21 January 2018

Detection of hepatocyte growth factor (HGF) ligand-c-MET receptor activation in formalin-fixed paraffin embedded specimens by a novel proximity assay

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12510

21 January 2018

Defective posttranslational processing activates the tyrosine kinase encoded by the MET proto-oncogene (hepatocyte growth factor receptor).

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12510

21 January 2018

Co-Activation of Epidermal Growth Factor Receptor and c-MET Defines a Distinct Subset of Lung Adenocarcinomas

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12510

21 January 2018

Hepatocyte growth factor twenty years on: Much more than a growth factor

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12510

21 January 2018

HGF/c-Met overexpressions, but not met mutation, correlates with progression of non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12510

21 January 2018

Biomarker analyses from a placebo-controlled phase II study evaluating erlotinib±onartuzumab in advanced non-small cell lung cancer: MET expression levels are predictive of patient benefit

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12510

21 January 2018

Identifiers

10.1111/HIS.12510

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/25039923

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/25039923

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53878549&oldid=1255219308"